Skip to main content

Table 1 Baseline characteristic for the 251 participants who completed the baseline testsa

From: Effect of vitamin D3 supplementation on iron status: a randomized, double-blind, placebo-controlled trial among ethnic minorities living in Norway

 

25 μg Vitamin D3

10 μg Vitamin D3

Placebo

N = 84

N = 85

N = 82

Age (years)

36.4 (8.2)

37.0 (7.6)

38.5 (7.6)

Gender, female N (%)

58 (69)

61 (72)

63 (77)

Region of origin N (%)

 South Asia

31 (37)

31 (36)

33 (40)

 Middle East and North Africa

15 (18)

9 (11)

12 (15)

 Sub-Sahara Africa

38 (45)

45 (53)

37 (45)

Body mass index

27.0 (5.2)

27.5(5.2)

27.8 (5.0)

 Female

27.7 (5.3)

27.7 (5.3)

28.9 (5.0)

 Male

25.0 (4.6)

26.3 (3.0)

24.5 (3,3)

S- 25(OH)D (nmol/L)

26.9 (16.4)

29.7 (20.5)

30.0 (19.0)

 Female

26.6 (17.3)

30.8 (22.3)

30.6 (19.8)

 Male

27.5 (14.6)

26.9 (15.2)

28.6 (16.2)

Hemoglobin (g/dL)b

13.6 (1.6)

13.7 (1.6)

13.6 (1.4)

 Female

12.8 (1.2)

13.1 (1.4)

13.0 (0.9)

 Male

15.2 (0.9)

15.1 (1.2)

15.5 (0.8)

Serum iron (μg/L)c

14.4 (6.6)

14.3 (5.7)

13.1 (5.7)

 Female

12.5 (5.5)

13.6 (5.8)

12.0 (5.4)

 Male

18.6 (6.8)

15.8 (5.3)

16.9 (4.9)

Serum ferritin (μg/L)c mean (SD)

58.9 (62.8)

81.6 (88.8)

56.3 (63.2)

 Female

33.1 (38.8)

46.4 (40.5)

34.1 (41.6)

 Male

116.7 (68.2)

171.4 (113.3)

129.6 (68.2)

Serum ferritin (μg/L) median (IQR)

 Female

22 (9.5–46.8)

36 (21–59)

24 (10–34.0)

 Male

104 (61–168)

145 (102–219)

110 (82–153)

Transferrin saturation (%)d

20.8 (10.4)

21.5 (9.3)

18.4 (8.4)

 Female

17.6 (8.8))

20.7 (10.0)

16.5 (7.8)

 Male

27.7 (10.3)

23.4 (7.4)

24.9 (6.4)

S-Total iron binding bapacity (μmol/L)c

72.1 (11.8)

68.6 (10.9)

72.9 (10.8)

 Female

74.0 (12.3)

68.9 (11.3)

74.3 (10.9)

 Male

67.6 (9.3)

67.5 (9.9)

68.3 (9.4)

S-Folic acid (nmol/L)c

14.8 (6.2)

15.9 (6.6)

15.8 (5.8)

 Female

15.5 (6.6)

15.3 (6.0)

15.9 (6.0)

 Male

13.4 (5.3)

17.8 (7.9)

15.6 (4.7)

S-Vitamin B12 (pmol/L)c

321.6 (92.7)

343.9 (116.8)

339.9 (105.5)

 Female

334.1 (93.8)

359.2 (119.8)

334.1 (110.9)

 Male

293.8 (85.9)

300.7 (98.6)

361.4 (82.1)

Plasma PTH (pmol/L)

 Female

7.3 (3.1)

7.5 (3.8)

8.5 (4.3)

 Male

8.0 (3.6)

6.8 (2.4)

6.3 (2.6)

S-CRP (mg/L)e

 All

4.9 (6.5)

4.0 (5.5)

4.2 (7.7)

 All (median, IQR)

1.8 (0.8–6.7)

1.8 (0.9–4.0)

2.0 (0.8–4.0)

  1. aData are mean (SD) unless specified otherwise
  2. bN = 209
  3. cReference range; s-ferritin (women and men > 16 years 15 -200 and 20 - 300 μg/L respectively), hemoglobin (women and men > 14 years 12–15.3 and 13.4–17), s-iron (women and men > 18 years 9–34 μmol/L), Transferrin saturation (women < 50 years 10–50 % and men 15–57 %), s-Folic acid >5.7 nmol/L and for s-vitamin B12 (170–650 pmol/L)
  4. d Iron/TIBC x 100
  5. e Serum C-reactive protein (CRP) included high-sensitivity CRP (hs CRP)